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Abstract 
MiR-34a, a direct target of p53, has shown to exert potent anti-proliferative effects. It has also 
been found that miR-34a can be induced by irradiation in vitro and in vivo. However, the 
relationship between miR-34a and radio-sensitivity, and its potential diagnostic significance in 
radiation biology, remain unclear. This study found that differing responses to ionizing radi-
ation (IR) of young and adult mice were related to miR-34a. First, we found that miR-34a 
could be induced in many organs by radiation of both young and adult mice. However, the 
level of miR-34a induced by young mice was much higher when compared to adult mice. Next, 
we found that miR-34a played a critical role in radio-sensitivity variations of different tissues 
by enhancing cell apoptosis and decreasing cell viability. We also found that the induction of 
miR-34a by radiation was in a p53 dependent manner and that one possible downstream 
target of miR-34a that lead to different radio-sensitivity was the anti-apoptosis molecular 
Bcl-2. However, over-expression of miR-34a and knockdown of Bcl-2 could significantly 
enhance the radio-sensitivity of different cells while inhibition of miR-34a could protect cells 
from radiation injury. Finally, we concluded that miR-34a could be stable in serum after IR and 
serve as a novel indicator of radiation injury. Taken together, this data strongly suggests that 
miR-34a may be a novel indicator, mediator and target of radiation injury, radio-sensitivity and 
radioprotection. 
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Introduction 
MicroRNAs (miRNAs,miRs) are a novel class of 
highly conserved, small, non-coding RNAs, about 22 
to 25 nucleotides in length, that have been shown to 
regulate gene expression in many important pathways 
in many organisms [1, 2]. These RNA molecules are 
produced from larger transcripts that are processed by 
RNase III enzyme Drosha/Pasha and Dicer [3]. Stud-
ies  showed  that  Drosha/Pasha  and  Dicer  work  se-Int. J. Biol. Sci. 2011, 7 
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quentially to generate mature 20–25 nucleotide miR-
NAs from the hairpin precursors [1]. They function by 
binding to the 3′UTR of multiple target mRNAs [4-6]. 
The bound mRNAs resulted in a decreased number of 
transcripts [7]. In animal cells, miRNAs play a vital 
role in development, cell proliferation, differentiation, 
apoptosis, and metabolism [8-10]. However, the role 
of miRNAs in radiation biology is unclear and only 
about 10 papers have been published on ionizing ra-
diation  (IR)  induced  miRNA  [11].  Two  papers  at-
tracted our attention were the change of miR-34a after 
IR [11, 12], and its potent anti-proliferative effects and 
ability to induce cell apoptosis [12-14]. It is well estab-
lished that miR-34a is a direct target of p53, whose 
induction by DNA damage depends on p53 [11]. Be-
sides, the role of p53 in the radio-sensitivity of differ-
ent  cells  and  tissues  has  been  extensively  studied 
[15-17]. It is well accepted that wild-type p53 is one of 
the key factors that enhanced the radio-sensitivity of 
many cells [16, 18] while the p53-mutated or deficient 
cells,  especially  some  p53  deficient  cancer  cells,  re-
spond very poorly to radiation [19, 20]. However, the 
role  of  miR-34a  in  age  and  tissue  related  ra-
dio-sensitivity  and  its’  potential  diagnostic  signifi-
cance in radiation biology, remain unclear. 
The  relationship  between  radio-sensitivity  and 
age has been recognized for many years [21-23]. Using 
a single dose, Abrams found that age, body weight, 
and  sex  could  influence  radiation  susceptibility[21]. 
The Sacher group and Crosfill group studied the rela-
tionship between radio-sensitivity and age systemati-
cally  and  found  that  young  mice  have  a  higher  ra-
dio-sensitivity than adult mice [22, 23]. Similar results 
were obtained by the Rotblat group [24, 25]. In 1971, 
Chaffey and Hellman found that differing responses 
to IR of murine bone marrow stem cells were related 
to the cell cycle[26]. However, in all of these studies 
the mechanism of age dependent radio-sensitivity was 
largely  ignored  and  the  role  of  miRNA  in  ra-
dio-sensitivity was given even less study.  
In this study, we first found that miR-34a could 
be induced in many organs by the radiation of both 
young and adult mice. However, the level of miR-34a 
induced by young mice was much higher when com-
pared to adult mice, which was closely correlated with 
the fact that young mice had a higher radio-sensitivity 
when compared to adult mice. Next, we found that 
miR-34a correlated closely with radio-sensitivity vari-
ations  of  different  tissues  in  genetic  normal  mice. 
However, the level of miR-34a induced by IR seems to 
be  in  a  p53  dependent  manner  since  the  level  of 
miR-34a  induced  by  IR  in  HCT116  p53-/-  cells  was 
decreased  significantly  when  compared  to  HCT116 
p53+/+ cells. Then, we used transfection assay to find 
that over-expression of miR-34a markedly suppressed 
cell proliferation and enhanced apoptosis both before 
and after radiation. Furthermore, we also found that 
the possible downstream target of miR-34a that led to 
different  radio-sensitivity  was  Bcl-2  since  the 
over-expression  of  miR-34a  and  the  knockdown  of 
Bcl-2 could significantly enhance the radio-sensitivity 
of different cells. Finally, we found that miR-34a could 
be detected not only in tissues, but also in mice serum, 
while the p53 mRNA could not be detected in mice 
serum  after  IR,  which  indicated  miR-34a  is  a  novel 
indicator of radiation injury. Taken together, our data 
demonstrated that miR-34a may be a novel indicator, 
mediator  and  target  of  radiation  injury,  ra-
dio-sensitivity and radioprotection. 
Materials and Methods 
Experimental animals and grouping  
Thirty young (3-4 weeks adult) and thirty adult 
(6-8 weeks adult) male BALB/c mice or C57BL/6 mice 
were  purchased  from  Chinese  academy  of  science 
(Shanghai, China). All mice were housed in a patho-
gen-free  facility  for  all  experiments.  All  animal  ex-
periments  were  undertaken  in  accordance  with  the 
National Institute of Health Guide for the Care and 
Use of Laboratory Animals, with the approval of the 
Laboratory Animal Center of Second Military Medical 
University, Shanghai. The approval ID for this study 
was 20081011. All efforts were made to minimize the 
number of animals used as well as their suffering. 
Cell culture  
Human glioblastoma-astrocytoma, epithelial-like 
cell line U87MG cells or Human Embryonic Kidney 
293  cells  HEK293  cells  were  obtained  from  the 
Shanghai Institute of Biochemistry and Cell Biology, 
Chinese  Academy  of  Sciences  (Shanghai,  China). 
HCT116  p53-/-  cells,  HCT116  p53+/+  cells  were  cul-
tured  in  24-well  plates  at  37 °C  in  a  humidified  at-
mosphere  of  5%  CO2  with  DMEM  Medium  (PAA, 
Austria) containing 10% fetal calf serum (PAA, Aus-
tria).  Exponentially  growing  cells  were  used  for  ex-
periments. 
Total-body irradiation 
 A 60Co irradiator was introduced for total-body 
ionizing  irradiation  as  described  in  our  previously 
studies  [27].  In  detail:  un-anaesthetized  mice  were 
placed in well-ventilated plastic boxes and exposed to 
the 60Co irradiator at a distance of 3 m from the source. 
A single dose of 7 Gy (or 2Gy and12 Gy) -radiation 
was delivered depending upon the requirement of the 
study. The dose rate was 1 Gy/min in this study. Int. J. Biol. Sci. 2011, 7 
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Survival Experiments 
Mice  were  irradiated  with  the  lethal  doses  de-
scribed above, and the survival was recorded daily up 
to day 30 after irradiation. Differences in survival of 
the  various  groups  of  mice  were  assessed  using 
Kaplan-Meier analyses and tested for significant dif-
ferences using the Log Rank test. Changes in median 
survival  (days  at  risk  after  exposure  or  sham  expo-
sure,  +/-  S.  E.)  with  increasing  dose  were  derived 
from  the  Kaplan-Meier  analyses  and  tested  by 
ANOVA for consistency with linear regression anal-
yses. 
RNA extraction  
RNA from different spleens, livers, thymus and 
cell lines was homogenized in Trizol (Invitrogen) and 
isolated according to the manufacturer's instructions 
as described previously [11]. RNA from serums was 
homogenized in mirVana™ PARIS™ Kit (Part Num-
ber AM1556, Applied Biosystems, USA) according to 
the  manufacturer's  instructions.  Concentration  and 
purity of total RNA samples were measured using the 
SmartSpec  Plus  spectrophotometer  (Bio-Rad,  Hercu-
les, CA). The ratio of A260:A280 was used to indicate 
the purity of total RNA. 
Reverse Transcription 
cDNA was generated using the miScript Reverse 
Transcription (RT) Kit (Qiagen GmbH, Hilden, Ger-
many). According to the manufacturer's instructions, 
1ug  total  RNA,  1ul  miScript  Reverse  Transcriptase 
Mix, and 4ul miScript RT buffer were mixed well and 
incubated for 60min at 37 C. All reverse transcriptions 
and no-template controls were run at the same time.  
Real-Time PCR  
Real-time polymerase chain reaction (PCR) was 
performed using miScript SYBR Green PCR Kit (Qi-
agen) on a Rotorgene 3000 series PCR machine (Cor-
bett  Research)  and  analyzed  with  software  of  Ro-
torgene System. The 20ul PCR mixture included 2ul 
reverse  transcription  product,  10ul  2×  QuantiTect 
SYBR Green PCR Master Mix, 2ul 10× miScript Uni-
versal  Primer,  2ul  10×  miScript  Primer  Assay  (for 
miR-34a; Qiagen), and 4ul autoclaved distilled water. 
The  reaction  mixtures  were  incubated  at  95°C  for 
10min, followed by 40 amplification cycles of 94 C for 
15s, 55 C for 30s, and 70 C for 30s. The threshold cycle 
(Ct)  was  defined  as  the  fractional  cycle  number  at 
which the fluorescence passed the fixed threshold. We 
also  quantified  transcripts  of  U6  small  RNA  using 
Hs_RNU6B_2  miScript  Primer  Assay  (Qiagen)  for 
normalizing  the  levels  of  miR-34a.  Small  RNAs  are 
preferred because they have similar purification and 
amplification characteristics to miRNAs. Choosing an 
appropriate  control  for  a  miRNA  quantification  ex-
periment  is  similar  to  choosing  an  appropriate 
housekeeping gene for normalization when quantify-
ing mRNA. For each sample type or treatment under 
study, it is necessary to verify that the control RNA is 
not regulated under the experimental conditions. In 
addition, a control for a non-coding RNA that shows a 
constant level of expression and similar abundance to 
the target miRNA should be chosen.U6 small RNA is a 
widely  used  endogenous  reference  RNA  in  miRNA 
quantification  studies.  Serum  miR-34a  was  normal-
ized to miR-16 or Exogenous U6 RNA as described 
previously [28-30] [31].The  ΔCt method was used for 
analysis. The experiment was repeated 3 times. The 
investigators were blinded to the results of clinical and 
pathological diagnosis. 
Transfection  
Cells were cultured and transfected as described 
previously [32]. Human glioblastoma-astrocytoma cell 
line U87MG cells; Human Embryonic Kidney 293 cells 
HEK293 cells, HCT116 p53-/- cells and HCT116 p53+/+ 
cells  were  seeded  at  6×104 cells  per  well  in  24-well 
plates and transfected with synthetic miRNAs (mim-
ics/inhibitors, genepharm, shanghai, china) at a final 
concentration of 50nM or 100nM using Lipofectamine 
2000  (Invitrogen,  ON,  Canada)  transfection  reagent 
according  to  the  manufacturer's  instructions  as  de-
scribed previously [32]. Three anti-Bcl-2 siRNA (siR-
NA  1,  siRNA  2  and  siRNA  3)  and  a  control 
non-targeting  siRNA  (siRNA  NC)  were  purchased 
from  genepharm  company  (genepharm,  shanghai, 
china) and they were transfected into cells similar to 
miRNA. Cells were infected 48 h later and subjected to 
further experiments.  
Apoptosis assay  
After different treatments, single cell suspension 
of Spleen, liver and thymus tissues were  made and 
labeled with annexin V-FITC and propidium iodide 
(PI)  provided  by  BIPEC,  following  manufacturer’s 
instructions  as  described  by  our  previously 
studies[27].  Samples  were  examined  by  ﬂuores-
cence-activated  cell  sorter  (FACS)  analysis,  and  the 
results  were  analyzed  using  Cell-Quest  software 
(Becton Dickinson, San Jose, CA). 
Cell Viability Analyses  
Trypan blue exclusion test were used for detect-
ing cell viability as previously described in our pre-
viously studies[26]. Briefly, after different treatments, 
single cell suspension of spleen, liver and thymus tis-
sues were made and labeled with Trypan Blue. The 
cellular  morphology  was  observed  using  Olympus Int. J. Biol. Sci. 2011, 7 
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BX60  fluorescent  microscope  equipped  with  Retiga 
2000R digital camera. Average percentage of Trypan 
Blue positives and negative cells were calculated in 5-7 
randomly  selected  high  power  field  (HPF).  Trypan 
Blue negative cells were regarded as living cells.  
Statistical analysis 
 Comparisons between experimental groups and 
relevant controls were performed by Student’s t-test. 
P< 0.05 was considered a statistically significant dif-
ference.  
Results  
MiR-34a is closely related to age related ra-
dio-sensitivity 
To study the role of miR-34a in age related ra-
dio-sensitivity, we first recorded the survival ability of 
different aged mice after receiving a total-body irra-
diation (TBI) at a single dose of 7 Gy. We found that 
the survival capacity of young (3-4 weeks old) mice 
was much lower than adult (6-8 weeks old) BALB/c 
mice after TBI (Figure 1A). This data indicated that 
young mice have a higher radio-sensitivity than adult 
mice. To further prove our finding, we also recorded 
the  survival  ability  of  different  aged  mice  after  re-
ceiving a single dose of 12 Gy TBI. The mean survival 
time of adult mice was 120 ± 24.0 h; while, the mean 
survival  time  was  significantly  decreased  in  young 
mice, which had a mean survival time of 72 ± 36 h 
(Figure 1A). We also found that Total-body irradiation 
suppressed the water consumption and food intake, 
and resulted in weight loss in both young as well as 
adult  mice.  However,  TBI  suppressed  young  mice 
were much more effective than adult mice (data not 
shown). Taken together, our data suggests that young 
mice have a higher radio-sensitivity when compared 
to  adult  mice.  Next,  we  studied  the  possibility  of 
miR-34a in age related radio-sensitivity. We first used 
q-RT-PCR analysis to detect the relative expression of 
miR-34a in different tissues from different aged mice. 
We found that miR-34a could be induced in the spleen 
by radiation of both young and adult mice 8 hours 
after  irradiation.  However,  the  level  of  miR-34a  in-
duced by young mice was much higher compared to 
adult mice (Figure 1B). Similar data was reported in 
thymus tissue after 7Gy total-body irradiation (Figure 
1B). The different ability to induce miR-34a by young 
and adult mice was closely related to the differences in 
their radio-sensitivity.  
To further study the time and dose response of 
miR-34a induced by different aged mice, we then de-
tected miR-34a level in spleen after 7Gy IR for various 
time periods and found that miR-34a can be induced 
by IR in a time-dependent manner (Figure 1C). We 
also detected the miR-34a level in spleen after 2Gy and 
12Gy  IR  and  found  that  2Gy  IR,  although  a  little 
weaker than 7 Gy IR and 12Gy IR, was enough to in-
duce miR-34a in spleen (Figure 1C).The time and dose 
response  also  showed  that  young  mice  have  higher 
ability to induce miR-34a than adult mice and these 
data  indicate  that  miR-34a  is  closely  related  to  age 
related radio-sensitivity.  
MiR-34a was correlated to radio-sensitivity vari-
ations of different tissues and mice strains. 
During our study of miR-34a in age related ra-
dio-sensitivity we found an interesting phenomenon. 
The relative level of miR-34a induced by IR in thymus 
tissues  was  much  higher  when  compared  to  spleen 
tissues  after  TBI  (Figure  1B  and  2C).  Indeed,  ra-
dio-sensitivity variations among different tissues were 
also an interesting issue and the role of miRNA in this 
area  is  still  not  clear.  Then  we  hypothesized  that 
miR-34a may not only play a role in age related ra-
dio-sensitivity,  but  also  a  novel  mediator  of  tissue 
related  radio-sensitivity  and  radiation  injury.  To 
prove  this  theory,  we  first  analyzed  the  ra-
dio-sensitivity  variations  among  different  spleen, 
thymus and liver tissues. We found that the spleen, 
thymus and liver have a similar apoptosis rate before 
radiation. However, the apoptosis rate of the liver is 
much lower than thymus after TBI, while the spleen 
has  a  middle  apoptosis  rate  between  the  liver  and 
thymus after TBI (Figure 2A and 2B); Consistent with 
the apoptosis data, the spleen, thymus and liver also 
have similar cell viability before radiation. However, 
the liver tissue has a much higher proliferate capacity 
than the thymus tissues, while the spleen has higher 
cell viability than the thymus but lower than the liver 
after  TBI  (Figure  2B).  This  data  indicates  that,  con-
sistent with previous studies, the thymus has a rela-
tively high radio-sensitivity while the liver has a fairly 
low radio-sensitivity and the radio-sensitivity of the 
spleen is between the two. Next we studied the possi-
bility  of  miR-34a  in  tissue  related  radio-sensitivity. 
Interestingly, we found that miR-34a could be induced 
in the thymus, liver and spleen by radiation in nearly 
every mouse. However, the relative level of miR-34a 
induced  in  the  thymus  tissue  is  much  higher  when 
compared  to  the  liver  after  TBI  (Figure  2C).  Spleen 
tissues also have a higher capacity to induce miR-34a 
compared  to  the  liver  and  slightly  higher  than  the 
thymus  after  TBI.  The  ability  to  induce  miR-34a  by 
different  tissues  was  closely  related  to  their  ra-
dio-sensitivity. These data also indicate that miR-34a 
is correlated to tissue related radio-sensitivity.  
 Int. J. Biol. Sci. 2011, 7 
 
http://www.biolsci.org 
225 
 
Figure 1. MiR-34a in age related radio-sensitivity. (A).Left: Yong or adult BALB/c mice were irradiated (+IR; 7Gy, dose rate 
1 Gy/min.) and survival time were recorded. Right: Survival time of mice in different groups after total-body irradiation (+IR; 
12Gy, dose rate 1 Gy/min.). N=20. (B) Yong or adult BALB/c mice were either irradiated (+IR; 7Gy, dose rate 1 Gy/min) or 
left untreated (con) and sacrificed 8 hr later, Spleen(left) or thymus (right) RNA was subjected to qRT-PCR analysis. N=6. 
(C) miR-34a can be induced by IR in a dose and time-dependent manner. Right: Yong or adult BALB/c mice were either 
irradiated (+IR; 7Gy, dose rate 1 Gy/min) or left untreated (con) and sacrificed 4,8,24 and 48 hr later, Spleen RNA was 
subjected to qRT-PCR analysis. N=6. Left: Yong or adult BALB/c mice were either irradiated with different doses (+IR; 2 Gy, 
7 Gy or 12 Gy, dose rate 1 Gy/min) or left untreated (con) and sacrificed 8 hr later, Spleen RNA was subjected to qRT-PCR 
analysis. Levels of miR-34a were normalized in the same sample and the level of miR-34a in adult un-irradiated mice was 
regarded as 100%. Data show the relative miR-34a expression level. N=6; *: P < 0.05. Int. J. Biol. Sci. 2011, 7 
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Figure 2. MiR-34a in radio-sensitivity variations of different tissues and mice strains. (A). BALB/c mice were irradiated with 
different doses (+IR; 2 Gy, 7 Gy or 12 Gy, dose rate 1 Gy/min) or left untreated (con) and sacrificed 24 hr later. Spleen, 
thymus and liver cells were stained with annexin V–FITC and PI and subjected to FACS assay of cellular apoptosis. N=6. Data 
showed a typical data of 3 repeats. (B). upper: BALB/c mice were irradiated (+IR; 7Gy, dose rate 0.8 Gy/min.) or left un-
treated then sacrificed 24 hr later for apoptosis assay. Figure showed statistical apoptosis rate of Spleen (Sp), thymus (Thy) 
and liver (Liv). Lower: BALB/c mice were irradiated (+IR; 7Gy, dose rate 1 Gy/min.) or left untreated then sacrificed 24 hr 
later. Spleen, thymus and liver cells were subjected to Trypan blue exclusion test for detection of cell viability. N=6. 
(C).BALB/c mice were irradiated (+IR; 7Gy, dose rate 1 Gy/min.) or left untreated then sacrificed 8 hr later. Spleen, thymus 
and liver cells RNA was subjected to qRT-PCR analysis. Levels of miR-34a were normalized in the same sample and the level 
of miR-34a in adult un-irradiated mice was regarded as 100%. Data show the relative miR-34a expression level. N=6. 
(D).BALB/c mice and C57BL/6 mice were irradiated (+IR; 7Gy, dose rate 1 Gy/min.) or left untreated then sacrificed 8 hr 
later. Spleen, thymus and liver cells RNA was subjected to qRT-PCR analysis. Levels of miR-34a were normalized in the same 
sample and the level of miR-34a in adult un-irradiated mice was regarded as 100%. Data show the relative miR-34a ex-
pression level of 7Gy compare to 0Gy in the same strain. N=6.*:P < 0.05; NS: No Significant difference detected. Int. J. Biol. Sci. 2011, 7 
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Since C57BL/6 mice are less sensitive to ionizing 
radiation than radiation sensitive strain BALB/c mice, 
we  then  detected  the  miR-34a  level  in  the  thymus, 
liver  and  spleen  from  C57BL/6  mice  and  BALB/c 
mice before and after 7 Gy IR and found that IR can 
induce  miR-34a  expression  in  thymus,  liver  and 
spleen tissues from both C57BL/6 mice and BALB/c 
mice  (Figure  2D),  however,  the  thymus  and  spleen 
from BALB/c mice showed higher miR-34a induction, 
while the livers from C57BL/6 mice and BALB/c mice 
showed  similar  miR-34a  enhancement.  These  data 
also  indicate  that  miR-34a  was  correlated  to  ra-
dio-sensitivity variations of different mice strains. 
The induction of MiR-34a by IR is in a p53 de-
pendent manner  
Since miR-34a is a direct target of p53 in many 
pathways [11], we next used p53 sufficient and defi-
cient cell line HCT116 p53+/+ cells and HCT116 p53-/- 
cells to study the possible relationship of miR-34a and 
p53  in  radio-sensitivity.  We  first  found  that  the  ra-
dio-sensitivity  of  HCT116  p53+/+  cells  was  signifi-
cantly higher than HCT116 p53-/- cells since HCT116 
p53+/+ cells displayed higher apoptosis cell rate and 
reduced cell viability than HCT116 p53-/- cells after 
the same dose of IR (Figure 3A and 3B).  
 
 
 
Figure 3. The induction of MiR-34a by IR is in a p53 dependent manner. (A/B). HCT116 p53
+/+ cells and HCT116 p53
-/- cells 
mice were irradiated with different doses (+IR; 2 Gy, 4 Gy or 8 Gy, dose rate 1 Gy/min) or left untreated (0 Gy) and 24 hr 
later cells were subjected to FACS assay (A) of cellular apoptosis and Trypan blue exclusion test for detection of cell 
viability(B). (C). HCT116 p53
+/+ cells and HCT116 p53
-/- cells mice were irradiated with different doses (+IR; 2 Gy, 4 Gy or 
8 Gy, dose rate 1 Gy/min) or left untreated (0 Gy) and 8 hr later cells were subjected to real-time PCR assay for detection 
of miR-34a level. (D). HCT116 p53
+/+ cells and HCT116 p53
-/- cells were irradiated with 4 Gy ( dose rate 1 Gy/min) irra-
diation and 0,4,8,24,48 hr later cells were subjected to real-time PCR assay for detection of miR-34a level. *:P < 0.05. Int. J. Biol. Sci. 2011, 7 
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This  result  was  consistent  with  the  previous 
concept  that  p53  enhanced  radio-sensitivity.  Fur-
thermore,  it  is  consistent  with  the  radio-sensitivity 
difference between these two cell lines. The relative 
level of miR-34a was also higher in HCT116 p53+/+ 
cells  than  in  HCT116  p53-/-  cells  (Figure  3C,  0Gy). 
Also, miR-34a was induced by IR in a dose and time 
related  manner  in  HCT116  p53+/+  cells,  but  not  in 
HCT116 p53-/- cells (Figure 3C and 3D). These data 
indicate that miR-34a is positively correlated to cellu-
lar radio-sensitivity and the induction of miR-34a was 
in a p53 dependent manner.  
MiR-34a maybe a critical mediator of radiation 
injury and may also be a critical target of radio-
protection 
Since miR-34a is closely related to age and tissue 
related radio-sensitivity, studies have shown that in-
activation of miR-34a strongly attenuates apoptosis in 
cells,  whereas  over-expression  of  miR-34a  increases 
apoptosis  [11].  Next  we  posited  that  miR-34a  may 
have  significant  function  on  radiation-induced  cell 
death. To prove our theory, we used in vitro transfec-
tion assays to explore the biological effects of miR-34a 
in  radiation  biology.  Human  glioblastoma  cell 
U87MG cells and human embryonic kidney HEK293 
cells  were  used  for  transfection.  We  found  that 
U87MG cells have a relatively lower miR-34a expres-
sion level than HEK293 cells and transient transfec-
tion of miR-34a mimics could lead to substantial in-
creased  production  of  mature  miR-34a  in  U87MG 
cells, while, transient transfection of miR-34a specific 
inhibitors  (anti-34a)  could  partly  knockdown  the 
production of miR-34a in 293 cells, as can be detected 
by qRT-PCR (Figure 4A).  
 
Figure 4. MiR-34a enhanced radiation induced apoptosis. (A) Relative miR-34a expression level in HEK293cells and U87MG 
cells and validation of miR-34a mimics (miR-34a) and miR-34a specific inhibitors (miR-34a ASO, antisense oligo). MiR-34a 
mimics and miR-34a ASO were transfected with nonspecific control miRNA mimics (NC) and NC ASO in to U87MG cells 
and HEK293cells as indicated for 24 hours, the relative levels of miR-34a were analyzed by qRT-PCR. (B) U87MG cells were 
transfected with nonspecific control NC or miR-34a for 48 hours and then subjected to radiation (+IR; 7Gy, dose rate 1 
Gy/min) or left untreated. After an additional 24 hours cells were stained with annexin V-FITC and PI and subjected to FACS 
assay of cellular apoptosis. (C) HEK 293 cells were transfected with miR-34a specific inhibitors (miR-34a ASO) or scrambled Int. J. Biol. Sci. 2011, 7 
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miRNA control (NC ASO) for 48 hr later. Then cells were exposed to irradiation (+IR; 7Gy, dose rate 1 Gy/min) or left 
untreated (con). After an additional 24hours cells were stained with annexin V and PI and subjected to FACS assay of cellular 
apoptosis. Data are representative of at least three wells. *:P < 0.05. 
 
 
More  importantly,  we  found  that 
over-expression  of  miR-34a  mimics  markedly  sup-
pressed cell proliferation and enhanced apoptosis in 
transfected  U87MG  cells  both  before  and  after  IR 
(Figure 4B, apoptosis; proliferation data not shown). 
Furthermore,  we  found  that  inhibition  of  miR-34a 
expression  could  markedly  decrease  the  apoptosis 
rate of HEK293 cells after 7Gy irradiation (Figure 4C). 
Similarly, over-expression of miR-34a mimics mark-
edly enhanced the radio-sensitivity of HCT116 p53-/- 
cells  while  inhibition  of  miR-34a  expression  could 
markedly  decrease  the  radio-sensitivity  of  HCT116 
p53+/+ cells (Figure 5A and 5B). These data indicate 
that miR-34a maybe a critical mediator of radiation 
injury and may also be a critical target of radioprotec-
tion. 
 
 
Figure 5.Over-expression of miR-34a mimics markedly enhanced the radio-sensitivity of HCT116 p53
-/- cells while inhi-
bition of miR-34a expression could markedly decrease the radio-sensitivity of HCT116 p53
+/+ cells. *: P < 0.05; NS: No 
Significant difference detected. 
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One possible downstream target of miR-34 that 
leads to different radio-sensitivity was Bcl-2 
MiRNAs  function  through  binding  and  inhibi-
tion of the 3′UTR of their target genes [4, 5]. A couple 
of  published  targets  (e.g.  cyclin-dependent  kinase 
(cdk) 4, cyclin E2, cMet, cdk6, and bcl-2) of miR-34a 
were identified by many groups [13, 14]. These mol-
ecules  have  been  proven  to  play  a  critical  role  in 
apoptosis, cell survival and cell cycle. We are partic-
ularly interested in Bcl-2 because many studies have 
shown  that  the  Bcl-2  family  proteins  are  key  mole-
cules that modulate radio-sensitivity in human cancer 
cells [33], specific, over-expression of bcl-2 has been 
proven to reduce the radio-sensitivity of many cancer 
cell lines [34] and Bcl-2 has been proven to be a direct 
target of miR-34a. To explore the relevance of Bcl-2 in 
miR-34a related radio-sensitivity, we performed Bcl-2 
KnockDown  (KD)  study.  Three  an-
ti-Bcl-2 siRNA (siRNA 1, siRNA 2 and 
siRNA  3)  and  a  control  non-targeting 
siRNA  (siRNA  NC)  were  transfected  into  U87MG 
cells and HCT116 p53-/- cells and we found that anti- 
Bcl-2 siRNA 1 showed the highest Bcl-2 knockdown 
capacity as detected by FACS assay (Figure 6A). We 
also found that KD of Bcl-2 (Bcl-2-KD), but not KD of 
nonspecific control (NC-KD), enhanced the apoptosis 
rate of the HCT116 p53-/- cells and U87MG cells after 
IR,  which  mimics  the  effects  of  miR-34a 
over-expression (Figure 6B). Furthermore, KD of Bcl-2 
also  attenuated,  but  not  fully  wiped  off  the  ra-
dio-protective  role  of  miR-34a  inhibitor  in  HEK293 
cells and HCT116 p53+/+ cells (Figure 6C). These data, 
taken together, indicate that although other possible 
downstream targets existed, one possible downstream 
target  of  miR-34a  that  leads  to  different  ra-
dio-sensitivity was Bcl-2. 
 
 
 
 
 
 
 
Figure 6. One possible downstream target 
of  miR-34a  that  leads  to  different  ra-
dio-sensitivity was Bcl-2. (A). Validation of 
three anti-Bcl-2 siRNA (siRNA 1, siRNA 2 
and siRNA 3) and  a  control non-targeting 
siRNA  (siRNA  NC)  in  transfected  into 
U87MG  cells  and  HCT116  p53
-/-  cells  48 
hours after transfection. (B). Knockdown of 
Bcl-2 (si-Bcl-2-1), but not KD of nonspecific 
control (si-NC), enhanced the apoptosis rate 
of the HCT116 p53
-/- cells and U87MG cells 
after IR, which mimics the effects of miR34a 
over-expression. (C). Knockdown of Bcl-2 
(si-Bcl-2) attenuated, but not fully wiped off, 
the radio-protective role of miR34a inhibitor 
in HEK293 cells and HCT116 p53
+/+ cells. *: 
P < 0.05. 
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Serum miR-34a as a Novel Indicator of Radiation 
injury 
It is of critical importance to develop novel bi-
omarkers  or indicators for individual radiation bio-
dosimetry of exposure to ionizing radiation [35, 36]. 
However, the potential miRNA indicators in radiation 
biology  are  largely  ignored.  Recent  studies  have 
shown that miRNAs are novel myocardial biomarker, 
and  potential  biomarkers  for  colorectal  cancer  and 
many  other  types  of  human  cancers  [37-39].  More 
importantly,  some  recent  studies  demonstrated  that 
plasma  or  serum  miRNAs  are  potential  biomarkers 
for some diseases [37-39]. We asked whether plasma 
or serum miR-34a can serve as a biomarker or indi-
cator  of  radiation  injury.  To  explore  this  issue,  we 
conducted  a  q-PCR  assay  to  detect  the  relative 
miR-34a level in different mice before and after 7Gy of 
TBI.  Consistently,  we  used  exogenous  U6  RNA  as 
loading  control  and  found  that  serum 
miR-34a, but not serum miR-16, was enhanced 
after irradiation (Figure 7A).  
We also found that miR-34a can be rap-
idly  induced  in  serum  from  irradiated  mice 
but not non-irradiated control mice, and the 
ratio of serum miR-34a vs. serum miR-16 from young 
mice was much higher compared to them from adult 
mice (Figure 7B). This is consistent with our previous 
data  on  the  role  of  miR-34a  in  age  related  ra-
dio-sensitivity. To gain the usefulness of miR-34a as 
biomarker or indicator, we also found that the ratio of 
serum  miR-34a  vs.  serum  miR-16  can  be  enhanced 
and  stable  for  48  hours  after  IR  and  2  Gy  IR  was 
enough  to  enhance  serum  miR-34a  (Figure  7C  and 
7D).  While,  although  played  important  role  in  ra-
dio-sensitivity, the mRNA of p53 and bcl-2 could not 
be detected in serum after IR (Data not shown). In our 
experiments, the serum levels of miR-34a (or the ratio 
of serum miR-34a vs. serum miR-16) are enhanced in 
many  dose  of  radiation.  However,  it  did  not  show 
clear  dose-response.  Therefore,  these  data  indicated 
that serum miR-34a may be useful to estimate radia-
tion exposure, but it still a long way to go for biodo-
simetry of radiation injury. 
 
Figure 7. Serum miR-34a is enhanced after Radia-
tion injury. (A).  Adult BALB/c  mice were either 
irradiated with different doses (+IR; 2 Gy, 7 Gy or 
12 Gy, dose rate 1 Gy/min) or left untreated (con) 
and sacrificed 8 hr later, Serum RNA was subjected 
to qRT-PCR analysis. Levels of miR-34a and miR-16 
were  normalized  to  exogenous  U6  RNA.  Data 
show the relative miR-34a and miR-16 expression 
level. N=6. (B) Yong or adult BALB/c mice were 
either irradiated (+IR; 7Gy, dose rate 1 Gy/min) or 
left untreated (con) and sacrificed 24 hr later. Se-
rum total RNA was subjected to qRT-PCR analysis. 
Levels of miR-34a were normalized to miR-16 in 
the same sample. Data show the relative miR-34a 
expression level. N=6. (C) Yong or adult BALB/c 
mice were either irradiated (+IR; 7Gy, dose rate 1 
Gy/min)  or  left  untreated  (con)  and  sacrificed 
4,8,24 and 48 hr later, Serum RNA was subjected 
to  qRT-PCR  analysis  for  detection  of  miR-34a. 
N=6. (D) Yong or adult BALB/c mice were either 
irradiated with different doses (+IR; 2 Gy, 7 Gy or 
12 Gy, dose rate 1 Gy/min) or left untreated (con) 
and sacrificed 8 hr later, Serum RNA was subjected 
to  qRT-PCR  analysis  for  detection  of 
miR-34a.Levels of miR-34a were normalized in the 
same  sample  and  the  level  of  miR-34a  in  adult 
un-irradiated  mice  was  regarded  as  100%.  Data 
show the relative miR-34a expression level. N=6. 
*:P < 0.05; NS: No Significant difference detected. Int. J. Biol. Sci. 2011, 7 
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Discussion 
Over 20 percent of cancer patients will require 
radiation therapy during the treatment of their dis-
ease. Radiation can induce significant damage and the 
development  of  radioprotectants  for  medical  and 
bio-defense  applications  are  very  important  [22,  23, 
40, 41]. Studies also show that miRNAs play pivotal 
roles in diverse processes such as development, dif-
ferentiation,  cell  proliferation,  stress  response  and 
cancer  [8,  9,  42,  43].  However,  there  has  been  very 
limited  study  demonstrating  the  role  of  miRNA  in 
radio-sensitivity  in  vivo  and  in  vitro.  Additionally, 
radiation damage biomarkers or indicators in miRNA 
levels are not well understood.  
In this study, we first found that miR-34a could 
be  induced  in  many  organs  by  radiation  of  both 
young and adult mice. However, the level of miR-34a 
induced by young mice was much higher compared 
to adult mice, which was closely correlated with the 
fact  that  young  mice  had  higher  radio-sensitivity 
when compared to adult mice. Next, we found that 
miR-34a correlated closely with radio-sensitivity var-
iations  of  different  tissues  in  genetic  normal  mice. 
However, the level of miR-34a induced by IR seems to 
be  in  a  p53  dependent  manner  since  the  level  of 
miR-34a  induced  by  IR  in  HCT116  p53-/-  cells  was 
decreased  significantly  when  compare  to  HCT116 
p53+/+ cells. Then, we used transfection assay to find 
that over-expression of miR-34a markedly suppressed 
cell  proliferation  and  enhanced  apoptosis  in  trans-
fected  U87MG  and  HCT116  p53-/-  cells  both  before 
and after radiation. Furthermore, We also found that 
the possible downstream target of miR-34 that lead to 
different  radio-sensitivity  was  Bcl-2  since 
over-expression  of  miR-34  and  knockdown  of  Bcl-2 
could  significantly  enhance  the  radio-sensitivity  of 
different cells. Finally, we found that miR-34a could 
be detected not only in tissues, but also in mice serum, 
while the p53 mRNA could not be detected in mice 
serum after IR, which indicated miR-34a as a novel 
biomarker  of  radiation  injury.  Taken  together,  our 
data demonstrated that miR-34a may be a novel in-
dicator,  mediator  and  target  of  radiation  injury,  ra-
dio-sensitivity and radioprotection. 
In  summary,  this  study  indicates  that  miR-34a 
has the potential to be a novel mediator and target of 
radiation  injury,  radio-sensitivity  and  radioprotec-
tion. 
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